Rabbit Recombinant Monoclonal IRF5 phospho S446 antibody. Suitable for WB, Dot and reacts with Human, Transfected cell lysate - Human, Synthetic peptide samples.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
WB | Dot | ICC/IF | Flow Cyt (Intra) | |
---|---|---|---|---|
Human | Tested | Expected | Not recommended | Not recommended |
Synthetic peptide | Not recommended | Tested | Not recommended | Not recommended |
Transfected cell lysate - Human | Tested | Not recommended | Not recommended | Not recommended |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/500 | Notes - |
Species Transfected cell lysate - Human | Dilution info 1/1000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Synthetic peptide | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Synthetic peptide | Dilution info 1/1000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Transfected cell lysate - Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Transfected cell lysate - Human, Synthetic peptide | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Transfected cell lysate - Human, Synthetic peptide | Dilution info - | Notes - |
Select an associated product type
Transcription factor that plays a critical role in innate immunity by activating expression of type I interferon (IFN) IFNA and INFB and inflammatory cytokines downstream of endolysosomal toll-like receptors TLR7, TLR8 and TLR9 (PubMed:11303025, PubMed:15695821, PubMed:22412986, PubMed:25326418, PubMed:32433612). Regulates the transcription of type I IFN genes (IFN-alpha and IFN-beta) and IFN-stimulated genes (ISG) by binding to an interferon-stimulated response element (ISRE) in their promoters (By similarity). Can efficiently activate both the IFN-beta (IFNB) and the IFN-alpha (IFNA) genes and mediate their induction downstream of the TLR-activated, MyD88-dependent pathway (By similarity). Key transcription factor regulating the IFN response during SARS-CoV-2 infection (PubMed:33440148).
Interferon regulatory factor 5, IRF-5, IRF5
Rabbit Recombinant Monoclonal IRF5 phospho S446 antibody. Suitable for WB, Dot and reacts with Human, Transfected cell lysate - Human, Synthetic peptide samples.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
IRF5 or Interferon Regulatory Factor 5 is a member of the IRF family of transcription factors. This protein weighs approximately 56 kDa and is expressed in cells of the immune system including B cells dendritic cells and macrophages. IRF5 plays an important role in regulating the transcription of interferon-stimulated genes following a viral infection. It acts by binding to specific DNA sequences initiating transcription processes that are important for the antiviral response.
IRF5 influences the immune response through the regulation of cytokine production. It activates genes involved in producing pro-inflammatory cytokines such as TNF-α and IL-6 which are important for clearing viral infections and activating immune cells. IRF5 does not usually form part of a protein complex but it interacts closely with TRAF6 and MyD88 for its activation. Its pivotal role in cytokine production highlights its importance in controlling inflammation.
IRF5 is an important component of the Toll-like receptor (TLR) signaling pathway and plays a role in the MyD88-dependent pathway. In this context IRF5 gets activated by TLRs interacting with MyD88 and TAK1 to enhance the transcription of important genes for immune response. It is also closely connected to the IRF3 protein which shares similar activation pathways and can similarly initiate an antiviral state.
Defects or dysregulation in IRF5 function are linked to autoimmune diseases such as systemic lupus erythematosus (SLE) and rheumatoid arthritis. In SLE IRF5 influences autoantibody production contributing to disease development. It works alongside other regulatory proteins involved in autoimmunity including IFN-α and STAT4 which also play significant roles in modulating immune responses. Understanding IRF5's role in these conditions could present new opportunities for therapeutic interventions using IRF5 inhibitors.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Blocking and diluting buffer and concentration: 5% NFDM/TBST.
All lanes: Western blot - Anti-IRF5 (phospho S446) antibody [EPR26132-254] (ab309088) at 1/500 dilution
Lane 1: Untreated THP-1 (human monocytic leukemia monocyte) overexpressing TLR9 whole cell lysate at 25 µg
Lane 2: THP-1 overexpressing TLR9 treated with CpG-B for 3 hours whole cell lysate at 25 µg
Lane 3: Untreated IRF5 knockout THP-1 overexpressing TLR9 whole cell lysate at 25 µg
Lane 4: IRF5 knockout THP-1 overexpressing TLR9 treated with CpG-B for 3 hours whole cell lysate at 25 µg
Predicted band size: 56 kDa
Observed band size: 56 kDa
Blocking and diluting buffer and concentration: 5% NFDM/TBST
In Western blot, anti-IRF5 antibody (Anti-IRF5 antibody [EPR17067] ab181553) staining at 1/1000 dilution.
Anti-GAPDH antibody (Anti-GAPDH antibody [EPR16891] - Loading Control ab181602) loading control staining at 1/200000 dilution.
All lanes: Western blot - Anti-IRF5 (phospho S446) antibody [EPR26132-254] (ab309088) at 1/1000 dilution
Lane 1: 293T cells transfected with a human IRF5 expression vector containing a His-tag whole cell lysate (untreated membrane) at 20 µg
Lane 2: 293T cells transfected with a human IRF5 expression vector containing a His-tag whole cell lysate (phosphatase treated membrane) at 20 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Observed band size: 56 kDa
Exposure time: 180s
Dot blot analysis of IRF5 (phospho S446) using ab309088 at 1:1000 (0.503 ug/ml) followed by a Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1:100,000 dilution.
Lane 1: IRF5 (phospho S446) peptide a
Lane 2: IRF5 (phospho S446) peptide b
Lane 3: IRF5 (phospho S446) non-phospho peptide c
Exposure time: 180 seconds
Blocking and diluting buffer and concentration: 5% NFDM/TBST
Blocking and diluting buffer and concentration: 5% NFDM/TBST
In Western blot, anti-His antibody (Anti-6X His tag® antibody [EPR20547] - ChIP Grade ab213204) staining at 1/5000 dilution.
Anti-GAPDH antibody (Anti-GAPDH antibody [EPR16891] - Loading Control ab181602) loading control staining at 1/200000 dilution.
Exposure time: 26 seconds
All lanes: Western blot - Anti-IRF5 (phospho S446) antibody [EPR26132-254] (ab309088) at 1/1000 dilution
Lane 1: 293T cells transfected with an empty vector containi a his tag whole cell lysate at 20 µg
Lane 2: 293T cells transfected with a human IRF5 expression vector containi a His-tag whole cell lysate at 20 µg
Lane 3: 293T cells transfected with a human IRF5 (S446D mutation) expression vector containi a His-tag whole cell lysate at 20 µg
Lane 4: 293T cells transfected with a human IRF5 (S446A mutation) expression vector containi a His-tag whole cell lysate at 20 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution
Observed band size: 56 kDa
Exposure time: 26s
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com